查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1618271

经导管心臟瓣膜置换术的全球市场:洞察，竞争情形，市场预测:2030年

Transcatheter Heart Valve Replacement - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计 2024 年至 2030 年期间，经导管心臟瓣膜置换术市场规模将以 13.75% 的复合年增长率扩大。经导管心臟瓣膜置换市场受到心血管疾病（包括各种心臟瓣膜疾病）盛行率的增加、监管许可、久坐生活方式和生活方式相关疾病等产品开发活动的增加的推动，由于人们对微创的偏好日益增加，该市场正在迅速扩大。

根据英国心臟基金会（BHF）的预测，到2024年，由于生活方式的改变、老化和人口增长，到2022年全球将有约6.4亿人患有心臟病和循环系统疾病。 ，他们居住在

根据世界卫生组织 (WHO) 2020 年数据，全球钙化性主动脉瓣狭窄盛行率为 900 万人。因此，心血管疾病（包括心血管疾病和各种心臟瓣膜疾病）盛行率的上升预计将增加对经导管心臟瓣膜置换术的需求。

患者对微创手术的偏好增加也可能是预测期内市场成长的好兆头。由于采用微创方法，与传统手术相比，经导管心臟瓣膜置换术可提供更快的恢復时间、更少的术后疼痛、更短的住院时间、更少的伤口併发症以及更好的伤口护理。

本报告提供全球经导管心臟瓣膜置换术市场相关调查，提供市场概要，以及各产品，各用途，各终端用户趋势，竞争情形，各国趋势等资讯。

目录

第1章 经导管心臟瓣膜置换术市场报告的简介

第2章 经导管心臟瓣膜置换术市场摘要整理

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 经导管心臟瓣膜置换术市场主要原因分析

  • 经导管心臟瓣膜置换术市场促进因素
  • 经导管心臟瓣膜置换术市场阻碍因素与课题
  • 经导管心臟瓣膜置换术市场机会

第6章 经导管心臟瓣膜置换术市场波特的五力分析

第7章 经导管心臟瓣膜置换术的市场评估

  • 各产品
  • 各用途
  • 各终端用户
  • 各地区

第8章 经导管心臟瓣膜置换术市场企业与产品简介

  • Medtronic
  • Boston Scientific Corporation
  • Bracco SpA
  • Edward Lifesciences
  • Meril Lifesciences
  • JenaValve Technologies Inc.
  • Venus Medtech (Hangzhou) Inc.
  • Abbott
  • Bluesail Medical Co., Ltd.
  • Braile Biomedica
  • CryoLife, Inc.
  • SMT
  • Peijia Medical Limited
  • P+F Products + Features GmbH
  • Livanova Plc

第9章 KOL的见解

第10章 计划的方法

第11章 关于DelveInsight

第12章 免责声明和咨询方式

Product Code: DIMDCL0431

Transcatheter Heart Valve Replacement Market by Product (Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Replacement, and Transcatheter Pulmonary Valve Replacement), Application (Aortic Valve Stenosis, Aortic Valve Regurgitation, Mitral Valve Stenosis, Mitral Valve Regurgitation, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the growing prevalence of cardiovascular disorders and increasing product developmental activities worldwide

The transcatheter heart valve replacement market is estimated to grow at a CAGR of 13.75% during the forecast period from 2024 to 2030. The transcatheter heart valve replacement market is expanding rapidly due to the growing prevalence of cardiovascular disorders including circulatory diseases, various heart valve diseases, increasing product developmental activities such as regulatory clearances, rising sedentary lifestyle & lifestyle-associated disorders, increasing preference for minimally invasive surgeries that are expected to escalate the overall growth of the transcatheter heart valve replacement market during the forecast period from 2024 to 2030.

Transcatheter Heart Valve Replacement Market Dynamics:

According to the British Heart Foundation (BHF), it was reported in 2024, that around 640 million people in 2022 were living with heart and circulatory diseases across the world owing to changing lifestyles, aging, and a growing population.

As per data from the World Health Organization (WHO) 2020, the prevalence of calcific aortic valve stenosis was 9 million across the world. Thus, the increasing prevalence of cardiovascular diseases including circulatory diseases and various heart valve diseases will increase the demand for transcatheter heart valve replacement.

The increasing patient preference for minimally invasive surgeries is also likely to bode well for the market growth during the forecast period. Transcatheter heart valve replacement offer advantages over conventional surgeries owing to their minimally invasive approach, such as shorter recovery time, less post-operational pain, less stay at the hospital, fewer wound complications, and better wound prosthesis.

Additionally, in February 2024, Edwards Lifesciences Corporation announced launch of the Sapien 3 Ultra Resilia valve in Europe.

Therefore, the factors stated above collectively will drive the overall transcatheter heart valve replacement market growth.

However, presence of alternative treatment in the market, stringent regulatory approval process, among others may prove to be challenging factors for transcatheter heart valve replacement market growth.

Transcatheter Heart Valve Replacement Market Segment Analysis:

Transcatheter Heart Valve Replacement Market by Product (Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Replacement, and Transcatheter Pulmonary Valve Replacement), Application (Aortic Valve Stenosis, Aortic Valve Regurgitation, Mitral Valve Stenosis, Mitral Valve Regurgitation, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the transcatheter heart valve replacement market, the transcatheter aortic valve replacement (TAVR) category is expected to have a significant revenue share in the year 2023. This is due to the increasing cases of aortic stenosis disorder as TAVR is the first-line surgical procedure performed for aortic stenosis. Further, the availability of technologically advanced devices in the market, and rising device launches and approvals will also affect the market positively.

The primary feature of this technique is its minimally invasive nature, as it involves accessing the aorta through the femoral artery in the groin, which typically results in a smaller incision and less surgical trauma. This approach leads to significant benefits, including a shorter recovery time.

Additionally, advancements in imaging and device technology have improved the precision of valve placement during the procedure, leading to better overall results. The transfemoral approach is also beneficial for patients with favorable femoral artery anatomy, as it allows for straightforward access without the need for complex surgical interventions.

Therefore the widespread uses and various features of transcatheter aortic valve replacement enhance performance and usability, solidifying the significant impact on the growth of the overall transcatheter heart valve replacement market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall transcatheter heart valve replacement market:

Among all the regions, North America is expected to dominate the transcatheter heart valve replacement market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high instances of myocardial infarction, heart valve diseases, and their associated risk factors, combined with significant advancements in product development & regulatory approvals, the presence of market key players, and the availability of well-established advanced healthcare infrastructure that are acting as key factors contributing to the growth of the transcatheter heart valve replacement market in the North America region during the forecast period from 2024 to 2030.

Disease Control and Prevention (CDC) (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. Furthermore, as per the same source, it was stated that heart disease is an umbrella term that encompasses numerous indications. Some of the key risk factors associated with heart disease are high blood cholesterol, high blood pressure, and smoking. The source further mentioned that about half of Americans (47%) have at least one of these three risk factors.

According to the Canadian Cardiovascular Society (2022), it was reported that in 2022, 2.5% of the population had heart valve diseases, which is increasing significantly after the age of 65, reaching up to 13% after the age of 75. It was also estimated by the same source that in 2040, Canada will have an estimated 1.5 million people over 65 years with heart valve disease.

Since cardiovascular disorders are rising in the region among middle-aged individuals, the demand for more effective treatment options is increasing significantly. This trend is fueling investment in innovative technologies and expanding the market for transcatheter heart valve replacement.

Rising product developmental activities by regulatory bodies and key players in the region will further boost the market for transcatheter heart valve replacement. For example, in September 2021, Abbott announced that the U.S Food and Drug Administration approved the company's Portico(TM) with FlexNav(TM) transcatheter aortic valve replacement (TAVR) system to treat people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American transcatheter heart valve replacement market.

Transcatheter Heart Valve Replacement Market key players:

Some of the key market players operating in the transcatheter heart valve replacement market include Medtronic, Boston Scientific Corporation, Bracco SpA, Edward Lifesciences, Meril Lifesciences, JenaValve Technologies Inc., Venus Medtech (Hangzhou) Inc., Abbott, Bluesail Medical Co., Ltd., Braile Biomedica, CryoLife, Inc., SMT, Peijia Medical Limited, P+F Products + Features GmbH, Livanova Plc, and others.

Recent Developmental Activities in the Transcatheter Heart Valve Replacement Market:

  • In August 2024, Boston Scientific Corporation announced that it secured CE mark for the ACURATE Prime(TM) Aortic Valve System, the newest transcatheter aortic valve replacement (TAVR) technology.
  • In January 2022, Medtronic announced that the National Medical Products Administration (NMPA) approved the CoreValve Evolut PRO TAVR system for the treatment of severe aortic stenosis (AS) for symptomatic patients in China who are at high or extreme risk for open heart surgery.

Key Takeaways from the Transcatheter Heart Valve Replacement Market Report Study

  • Market size analysis for current transcatheter heart valve replacement market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the transcatheter heart valve replacement market
  • Various opportunities available for the other competitors in the Transcatheter Heart Valve Replacement market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current transcatheter heart valve replacement market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for transcatheter heart valve replacement market growth in the coming future?

Target Audience who can be benefited from this Transcatheter Heart Valve Replacement Market Report Study

  • Transcatheter heart valve replacement product providers
  • Research organizations and consulting companies
  • Transcatheter heart valve replacement-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in transcatheter heart valve replacement
  • Various end-users who want to know more about the transcatheter heart valve replacement market and the latest technological developments in the transcatheter heart valve replacement market

Frequently Asked Questions for the Transcatheter Heart Valve Replacement Market:

1. What are transcatheter heart valve replacement?

  • The transcatheter heart valve replacement is a procedure with a less invasive approach that helps replace the heart valve with a prosthetic valve to treat severe aortic stenosis and mitral regurgitation. It is an effective alternative to cumbersome open heart surgery, especially for high-risk patients.

2. What is the market for transcatheter heart valve replacement?

  • The transcatheter heart valve replacement market is estimated to grow at a CAGR of 13.75% during the forecast period from 2024 to 2030.

3. What are the drivers for the transcatheter heart valve replacement market?

  • The transcatheter heart valve replacement market is expanding rapidly due to the growing prevalence of cardiovascular disorders including circulatory diseases, various heart valve diseases, increasing product developmental activities such as regulatory clearances, rising sedentary lifestyle & lifestyle-associated disorders, increasing preference for minimally invasive surgeries that are expected to escalate the overall growth of the transcatheter heart valve replacement market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the transcatheter heart valve replacement market?

  • Some of the key market players operating in transcatheter heart valve replacement include Medtronic, Boston Scientific Corporation, Bracco SpA, Edward Lifesciences, Meril Lifesciences, JenaValve Technologies Inc., Venus Medtech (Hangzhou) Inc., Abbott, Bluesail Medical Co., Ltd., Braile Biomedica, CryoLife, Inc., SMT, Peijia Medical Limited, P+F Products + Features GmbH, Livanova Plc, and others.

5. Which region has the highest share in the transcatheter heart valve replacement market?

  • Among all the regions, North America is expected to dominate the transcatheter heart valve replacement market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high instances of myocardial infarction, heart valve diseases, and its associated risk factors, combined with significant advancements in product development & regulatory approvals, the presence of market key players, and the availability of well-established advanced healthcare infrastructure that are acting as key factors contributing to the growth of the transcatheter heart valve replacement market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Transcatheter Heart Valve Replacement Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Transcatheter Heart Valve Replacement Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Transcatheter Heart Valve Replacement Market Key Factors Analysis

  • 5.1. Transcatheter Heart Valve Replacement Market Drivers
    • 5.1.1. Growing prevalence of cardiovascular disorders
    • 5.1.2. Increasing product developmental activities
    • 5.1.3. Rising sedentary lifestyle and Increasing prevalence of lifestyle-associated disorders
  • 5.2. Transcatheter Heart Valve Replacement Market Restraints and Challenges
    • 5.2.1. Presence of alternative treatment in the market
    • 5.2.2. Stringent regulatory approval process
  • 5.3. Transcatheter Heart Valve Replacement Market Opportunities
    • 5.3.1. Presence of a robust number of replacement devices in the pipeline

6. Transcatheter Heart Valve Replacement Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Transcatheter Heart Valve Replacement Market Assessment

  • 7.1. By Product
    • 7.1.1. Transcatheter Aortic Valve Replacement
    • 7.1.2. Transcatheter Mitral Valve Replacement
    • 7.1.3. Transcatheter Pulmonary Valve Replacement
  • 7.2. By Application
    • 7.2.1. Aortic Valve Stenosis
    • 7.2.2. Aortic Valve Regurgitation
    • 7.2.3. Mitral Valve Stenosis
    • 7.2.4. Mitral Valve Regurgitation
    • 7.2.5. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
      • 7.4.1.2. Canada Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
      • 7.4.1.3. Mexico Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
      • 7.4.2.2. Germany Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
      • 7.4.2.4. Italy Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
      • 7.4.2.5. Spain Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
      • 7.4.3.2. Japan Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
      • 7.4.3.3. India Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
      • 7.4.3.4. Australia Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
      • 7.4.3.5. South Korea Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
      • 7.4.4.2. Africa Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)
      • 7.4.4.3. South America Transcatheter Heart Valve Replacement Market Size in USD million (2021-2030)

8. Transcatheter Heart Valve Replacement Market Company and Product Profiles

  • 8.1. Medtronic
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Boston Scientific Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Bracco SpA
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Edward Lifesciences
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Meril Lifesciences
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. JenaValve Technologies Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Venus Medtech (Hangzhou) Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Abbott
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Bluesail Medical Co., Ltd.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Braile Biomedica
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. CryoLife, Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. SMT
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Peijia Medical Limited
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. P+F Products + Features GmbH
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Livanova Plc
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Transcatheter Heart Valve Replacement Market in Global (2021-2030)
  • Table 3: Transcatheter Heart Valve Replacement Market in Global by Product (2021-2030)
  • Table 4: Transcatheter Heart Valve Replacement Market in Global by Application (2021-2030)
  • Table 5: Transcatheter Heart Valve Replacement Market in Global by End-User (2021-2030)
  • Table 6: Transcatheter Heart Valve Replacement Market in Global by Geography (2021-2030)
  • Table 7: Transcatheter Heart Valve Replacement Market in North America (2021-2030)
  • Table 8: Transcatheter Heart Valve Replacement Market in the United States (2021-2030)
  • Table 9: Transcatheter Heart Valve Replacement Market in Canada (2021-2030)
  • Table 10: Transcatheter Heart Valve Replacement Market in Mexico (2021-2030)
  • Table 11: Transcatheter Heart Valve Replacement Market in Europe (2021-2030)
  • Table 12: Transcatheter Heart Valve Replacement Market in France (2021-2030)
  • Table 13: Transcatheter Heart Valve Replacement Market in Germany (2021-2030)
  • Table 14: Transcatheter Heart Valve Replacement Market in United Kingdom (2021-2030)
  • Table 15: Transcatheter Heart Valve Replacement Market in Italy (2021-2030)
  • Table 16: Transcatheter Heart Valve Replacement Market in Spain (2021-2030)
  • Table 17: Transcatheter Heart Valve Replacement Market in the Rest of Europe (2021-2030)
  • Table 18: Transcatheter Heart Valve Replacement Market in Asia-Pacific (2021-2030)
  • Table 19: Transcatheter Heart Valve Replacement Market in China (2021-2030)
  • Table 20: Transcatheter Heart Valve Replacement Market in Japan (2021-2030)
  • Table 21: Transcatheter Heart Valve Replacement Market in India (2021-2030)
  • Table 22: Transcatheter Heart Valve Replacement Market in Australia (2021-2030)
  • Table 23: Transcatheter Heart Valve Replacement Market in South Korea (2021-2030)
  • Table 24: Transcatheter Heart Valve Replacement Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Transcatheter Heart Valve Replacement Market in the Rest of the World (2021-2030)
  • Table 26: Transcatheter Heart Valve Replacement Market in the Middle East (2021-2030)
  • Table 27: Transcatheter Heart Valve Replacement Market in Africa (2021-2030)
  • Table 28: Transcatheter Heart Valve Replacement Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Transcatheter Heart Valve Replacement Market in Global (2021-2030)
  • Figure 3: Transcatheter Heart Valve Replacement Market in Global by Product (2021-2030)
  • Figure 4: Transcatheter Heart Valve Replacement Market in Global by Application (2021-2030)
  • Figure 5: Transcatheter Heart Valve Replacement Market in Global by End-User (2021-2030)
  • Figure 6: Transcatheter Heart Valve Replacement Market in Global by Geography (2021-2030)
  • Figure 7: Transcatheter Heart Valve Replacement Market in North America (2021-2030)
  • Figure 8: Transcatheter Heart Valve Replacement Market in the United States (2021-2030)
  • Figure 9: Transcatheter Heart Valve Replacement Market in Canada (2021-2030)
  • Figure 10: Transcatheter Heart Valve Replacement Market in Mexico (2021-2030)
  • Figure 11: Transcatheter Heart Valve Replacement Market in Europe (2021-2030)
  • Figure 12: Transcatheter Heart Valve Replacement Market in France (2021-2030)
  • Figure 13: Transcatheter Heart Valve Replacement Market in Germany (2021-2030)
  • Figure 14: Transcatheter Heart Valve Replacement Market in United Kingdom (2021-2030)
  • Figure 15: Transcatheter Heart Valve Replacement Market in Italy (2021-2030)
  • Figure 16: Transcatheter Heart Valve Replacement Market in Spain (2021-2030)
  • Figure 17: Transcatheter Heart Valve Replacement Market in the Rest of Europe (2021-2030)
  • Figure 18: Transcatheter Heart Valve Replacement Market in Asia-Pacific (2021-2030)
  • Figure 19: Transcatheter Heart Valve Replacement Market in China (2021-2030)
  • Figure 20: Transcatheter Heart Valve Replacement Market in Japan (2021-2030)
  • Figure 21: Transcatheter Heart Valve Replacement Market in India (2021-2030)
  • Figure 22: Transcatheter Heart Valve Replacement Market in Australia (2021-2030)
  • Figure 23: Transcatheter Heart Valve Replacement Market in South Korea (2021-2030)
  • Figure 24: Transcatheter Heart Valve Replacement Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Transcatheter Heart Valve Replacement Market in the Rest of the World (2021-2030)
  • Figure 26: Transcatheter Heart Valve Replacement Market in the Middle East (2021-2030)
  • Figure 27: Transcatheter Heart Valve Replacement Market in Africa (2021-2030)
  • Figure 28: Transcatheter Heart Valve Replacement Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis